-

Hims & Hers Certified as a ‘Great Place to Work’

Results from a new survey of Hims & Hers’ employees has certified the company as a ‘great place to work’ for 2023

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, has been certified as a great place to work this month by the independent analyst Great Place to Work® for the year 2023.

The certification was based on anonymous feedback from Hims & Hers' employees who responded to a survey looking at multiple aspects of the company such as leadership and workplace practices. Results from the survey said that 91% of employees listed Hims & Hers as a great place to work, compared to 57% of employees at “a typical U.S.-based company.”

"We are honored to be certified by Great Place to Work®," said Andrew Dudum, Co-founder and CEO of Hims & Hers. "Our employees are a talented and passionate group of individuals who strive to enhance the lives of our consumers, holding true to our mission to help the world feel great. Every employee at Hims & Hers knows our mission is deeply personal—because we too are customers."

This certification shows that Hims & Hers has demonstrated excellence in the workplace and are committed to providing an inclusive work environment resulting in high levels of employee satisfaction.

About Hims & Hers Health, Inc.

Hims & Hers is the leading health and wellness platform on a mission to help the world feel great through the power of better health.

We believe how you feel in your body and mind transforms how you show up in life. That’s why we’re building a future where nothing stands in the way of harnessing this power. Hims & Hers normalizes health & wellness challenges—and innovates on their solutions—to make feeling happy and healthy easy to achieve. No two people are the same, so the Company provides access to personalized care designed for results.

Hims & Hers Health, Inc.

NYSE:HIMS

Release Versions

More News From Hims & Hers Health, Inc.

Hims & Hers Nominates Kofi Amoo-Gottfried to its Board of Directors

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, has nominated Kofi Amoo-Gottfried for election as a new director at the company’s 2026 annual shareholder meeting in June. Amoo-Gottfried is a seasoned marketing leader with decades of experience helping global transformative brands change how consumers think about their everyday lives. He served as Chief Marketing Officer at DoorDash and in leadership roles at...

Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will report first quarter 2026 financial results after the market closes on Monday, May 11, 2026. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day. The conference call can be accessed by dialing (888) 510-2630 for U.S. participants and (646) 960-0137 for international participants, referenc...

Novo Nordisk’s FDA-Approved GLP-1s Now Available With Hims & Hers

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS) today announced that a broad assortment of Novo Nordisk’s FDA-approved GLP-1 medications are available to eligible customers, including the Wegovy® pill, which is the only FDA-approved GLP-1 weight loss pill.1 As a part of a collaboration with Novo Nordisk, Hims & Hers is making it simpler for customers to access FDA-approved GLP-1 medications which are now available at more affordable prices, with more doses and deli...
Back to Newsroom